查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571428

DNA 诊断市场规模、份额、趋势分析报告：按技术、按应用、按地区、细分市场预测，2024-2030 年

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics), By Application (Cancer Genetics Tests), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

DNA 诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球DNA诊断市场规模将达141.4亿美元，2024年至2030年复合年增长率为4.51%。

该市场的成长得益于基因组解码的进步和个人化 DNA 级诊断应用的开拓。此外，越来越多的政府资助的专利研究计划和资助计划预计将进一步推动市场需求。例如，2022 年 12 月，英国政府宣布提供 2.294 亿美元（1.75 亿日圆）资金用于高级基因组研究的开发和创建。

基因组分析新技术的引入极大地推动了市场的成长。此外，随着依赖 DNA原型製作进行个人化医学治疗和诊断的慢性肿瘤和感染疾病的盛行率不断增加，基于 DNA 诊断/测试的研究的需求预计将在预测期内显着增加。此外，产前检测和体外受精需求的成长推动了 DNA 诊断/测试需求的成长，预计这将为市场提供积极的成长前景。 2022年9月，Eurofins Genoma宣布推出niPGT-A，这是一种无胚胎、非侵入性胚胎着床前筛检测试。

DNA 诊断可以透过次世代定序(NGS) 等技术对肿瘤基因组进行全面分析。 NGS 允许同时对多个基因进行定序，提供肿瘤中存在的遗传改变的详细视图。透过将肿瘤基因组与正常组织 DNA 进行比较，科学家和临床医生可以识别癌细胞特有的突变、拷贝数变异和结构重排。 2022 年 6 月，DNA 定序和基于阵列的技术提供者 Illumina 将宣布与默克公司合作开发的一项研究测试，旨在深入了解肿瘤基因组。

C型肝炎病毒(HCV) 是一个全球性健康问题，影响着全世界数百万人。准确、及时的诊断HCV对于有效治疗和预防进一步传播至关重要。在此背景下，DNA 诊断已成为检测和管理 HCV 感染的强大工具。 2022年7月，罗氏推出了突破性抗原抗体双重诊断测试Elecsys HCV Duo，支持全球消除C型肝炎病毒的努力。

DNA 诊断市场报告亮点

  • 基于PCR的诊断领域在2023年占最大份额，达到50.36%。该细分市场的主导地位归因于越来越多的主要企业引入基于 PCR 的创新诊断技术，从而导致更广泛的市场采用和更高的产品可用性。
  • 由于可实现全面基因分析的高通量定序技术的进步，次世代定序(NGS) DNA 诊断预计在预测期内将以 9.65% 的复合年增长率快速增长。
  • 癌症基因检测细分市场占比最大，2023年为29.47%。 DNA测序技术越来越多地用于识别和表征各种癌症类型和遗传疾病。
  • 北美DNA诊断市场在全球整体市场中占据主导地位，2023年占43.20%的销售份额。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 DNA 诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • DNA诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 DNA诊断市场：技术预估与趋势分析

  • 细分仪表板
  • DNA诊断市场：技术波动分析
  • DNA 诊断市场：技术展望
  • 2018-2030 年市场规模与预测/趋势分析
  • 基于PCR的诊断
  • NGS DNA诊断
  • 原位杂交诊断
  • 基于微阵列的诊断
  • 其他技术

第五章 DNA诊断市场：使用量估算与趋势分析

  • 细分仪表板
  • DNA诊断市场：应用变异分析
  • DNA 诊断市场：按应用分類的前景
  • 2018-2030 年市场规模与预测/趋势分析
  • 癌症基因检测
  • 感染疾病DNA检测
    • 乙型肝炎诊断
    • 结核病诊断
    • CT/NG诊断
    • HPV诊断
    • 耐甲氧西林金黄色葡萄球菌诊断
    • 其他的
  • 新生儿基因筛检
  • 胚胎着床前诊断与生殖诊断
  • 非传染性疾病的 DNA 检测
    • 心血管疾病
    • CNS和PNS相关
    • 骨骼、结缔组织、外胚层和真皮的 DNA 检测
    • 肺、肾、肝、消化系统相关
    • 感觉疾病
  • 产前DNA携带者筛检
  • 药物基因体学/药物代谢
  • 血液学和免疫学/鑑定和法医学
  • 其他的

第六章 DNA诊断市场：区域估算与趋势分析

  • 细分仪表板
  • 2018-2030 年市场规模与预测/趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 市场参与企业分类
  • 公司分类
  • 策略规划
    • 新产品发布
    • 伙伴关係
    • 获得
    • 合作
  • 2023年主要企业市场占有率分析
  • 主要企业简介
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Hologic, Inc.
    • Agilent Technologies Inc.
    • Siemens Healthineers AG
    • Danaher Corporation
Product Code: 978-1-68038-676-9

DNA Diagnostics Market Growth & Trends:

The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 4.51% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights:

  • The PCR-based diagnostics segment held the largest share of 50.36% in 2023, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics
  • NGS DNA diagnosis is projected to grow fastest CAGR of 9.65% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.
  • Cancer genetics tests segment held the largest share of 29.47% in 2023. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.
  • North America DNA diagnostics market dominated the overall global market and accounted for the 43.20 %revenue share in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. DNA Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. DNA Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. DNA Diagnostics Market: Technology Movement Analysis
  • 4.3. DNA Diagnostics Market by Technology Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. PCR-based Diagnostics
    • 4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. NGS DNA Diagnosis
    • 4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. In-Situ Hybridization Diagnostics
    • 4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Microarrays-based Diagnostics
    • 4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Other Technologies
    • 4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. DNA Diagnostics Market: Application Movement Analysis
  • 5.3. DNA Diagnostics Market by Application Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Cancer Genetics Tests
    • 5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Infectious Diseases DNA Testing
    • 5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. HBV Diagnostic
      • 5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. TB Diagnostic
      • 5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. CT/NG Diagnostic
      • 5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. HPV Diagnostic
      • 5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. MRSA Diagnostic
      • 5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Others
      • 5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Newborn Genetic Screening
    • 5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Preimplantation & Reproductive Diagnosis
    • 5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Non-Infectious Diseases DNA Testing
    • 5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.2. Cardiovascular Diseases
      • 5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.3. CNS & PNS Related
      • 5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
      • 5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.5. Lung, Kidney, Liver & GT Related
      • 5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.6. Sensory Diseases
      • 5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. Prenatal DNA Carrier Screening
    • 5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. Pharmacogenomics/Drug Metabolism
    • 5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.12. Hematology & Immunology/Identity Diagnostics & Forensics
    • 5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.13. Others
    • 5.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional DNA Diagnostics Market movement analysis
  • 6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Competitive Scenario
    • 6.5.3. Canada
      • 6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Competitive Scenario
    • 6.5.4. Mexico
      • 6.5.4.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Scenario
      • 6.5.4.5. Competitive Scenario
  • 6.6. Europe
    • 6.6.1. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. UK
      • 6.6.2.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Competitive Scenario
    • 6.6.3. Germany
      • 6.6.3.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Competitive Scenario
    • 6.6.4. France
      • 6.6.4.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. Competitive Scenario
    • 6.6.5. Italy
      • 6.6.5.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Competitive Scenario
    • 6.6.6. Spain
      • 6.6.6.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.6.2. Key Country Dynamics
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Scenario
      • 6.6.6.5. Competitive Scenario
    • 6.6.7. Denmark
      • 6.6.7.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.7.2. Key Country Dynamics
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Scenario
      • 6.6.7.5. Competitive Scenario
    • 6.6.8. Norway
      • 6.6.8.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.8.2. Key Country Dynamics
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement Scenario
      • 6.6.8.5. Competitive Scenario
    • 6.6.9. Sweden
      • 6.6.9.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.6.9.2. Key Country Dynamics
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement Scenario
      • 6.6.9.5. Competitive Scenario
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Japan
      • 6.7.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Scenario
      • 6.7.2.5. Competitive Scenario
    • 6.7.3. China
      • 6.7.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Scenario
      • 6.7.3.5. Competitive Scenario
    • 6.7.4. India
      • 6.7.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement Scenario
      • 6.7.4.5. Competitive Scenario
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.5.2. Key Country Dynamics
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement Scenario
      • 6.7.5.5. Competitive Scenario
    • 6.7.6. Australia
      • 6.7.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.6.2. Key Country Dynamics
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement Scenario
      • 6.7.6.5. Competitive Scenario
    • 6.7.7. Thailand
      • 6.7.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.7.7.2. Key Country Dynamics
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement Scenario
      • 6.7.7.5. Competitive Scenario
  • 6.8. Latin America
    • 6.8.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. Brazil
      • 6.8.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.8.2.2. Key Country Dynamics
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Scenario
      • 6.8.2.5. Competitive Scenario
    • 6.8.3. Argentina
      • 6.8.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.8.3.2. Key Country Dynamics
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Scenario
      • 6.8.3.5. Competitive Scenario
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.9.2. South Africa
      • 6.9.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.9.2.2. Key Country Dynamics
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement Scenario
      • 6.9.2.5. Competitive Scenario
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.9.3.2. Key Country Dynamics
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement Scenario
      • 6.9.3.5. Competitive Scenario
    • 6.9.4. UAE
      • 6.9.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.9.4.2. Key Country Dynamics
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement Scenario
      • 6.9.4.5. Competitive Scenario
    • 6.9.5. Kuwait
      • 6.9.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 6.9.5.2. Key Country Dynamics
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement Scenario
      • 6.9.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Categorization
  • 7.3. Strategy Mapping
    • 7.3.1. NEW PRODUCT LAUNCH
    • 7.3.2. PARTNERSHIPS
    • 7.3.3. ACQUISITION
    • 7.3.4. COLLABORATION
  • 7.4. Key Company Market Share Analysis, 2023
  • 7.5. Key Company Profiles
    • 7.5.1. Abbott
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Technology benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. F. Hoffmann-La Roche Ltd.
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Technology benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. QIAGEN
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Technology benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Technology benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Thermo Fisher Scientific, Inc.
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Technology benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Illumina, Inc.
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Technology benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Hologic, Inc.
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Technology benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Agilent Technologies Inc.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Technology benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Siemens Healthineers AG
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Technology benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Danaher Corporation
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Technology benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 4 Global DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America DNA diagnostics market, by region, 2018 - 2030 (USD Billion)
  • Table 6 North America DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 7 North America DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 8 U.S. DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 9 U.S. DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 10 Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 11 Canada DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 12 Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 13 Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 14 Europe DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 15 Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 16 Europe DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 17 UK DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 18 UK DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 20 Germany DNA diagnostics market, by application 2018 - 2030 (USD Billion)
  • Table 21 France DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 22 France DNA diagnostics market, by application 2018 - 2030 (USD Billion)
  • Table 23 Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 24 Italy DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 25 Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 26 Spain DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 27 Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 28 Denmark DNA diagnostics market, by application 2018 - 2030 (USD Billion)
  • Table 29 Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 30 Norway DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 31 Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 32 Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 33 Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 37 Japan DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 38 China DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 39 China DNA diagnostics market, by application 2018 - 2030 (USD Billion)
  • Table 40 India DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 41 India DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 42 Australia DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 43 Australia DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 44 South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 45 South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 46 Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 47 Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 49 Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 51 Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 52 Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 53 Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 54 Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 55 Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
  • Table 56 Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 58 South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 59 South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 60 Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 62 UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 63 UAE DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
  • Table 64 Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 DNA diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology snapshot
  • Fig. 10 Application snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market value, 2023 (USD Billion)
  • Fig. 13 Market dynamics
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 DNA diagnostics market: Technology outlook and key takeaways
  • Fig. 17 DNA diagnostics market: Technology movement analysis
  • Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 DNA diagnostics market: Application outlook and key takeaways
  • Fig. 24 DNA diagnostics market: Application movement analysis
  • Fig. 25 Cancer genetics tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 HBV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 TB diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 HPV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 MRSA diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 CNS & PNS related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Sensory diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 DNA diagnostics market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China regulatory details
  • Fig. 79 Key country dynamics
  • Fig. 80 India DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Korean regulations in four hierarchical orders
  • Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key company categorization
  • Fig. 106 Heat map analysis
  • Fig. 107 Strategic framework